Invivyd Market Capitalization from 2010 to 2024
| IVVD Stock | USD 0.44 0.01 2.33% |
Check Invivyd financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Invivyd's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Other Operating Expenses of 197.7 M or Research Development of 160.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.55. Invivyd financial statements analysis is a perfect complement when working with Invivyd Valuation or Volatility modules.
Invivyd | Market Capitalization |
Latest Invivyd's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Invivyd over the last few years. It is Invivyd's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Invivyd's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 51.4 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Invivyd Market Capitalization Regression Statistics
| Arithmetic Mean | 1,823,938,547 | |
| Geometric Mean | 1,443,200,958 | |
| Coefficient Of Variation | 47.43 | |
| Mean Deviation | 731,677,223 | |
| Median | 2,322,809,381 | |
| Standard Deviation | 865,040,536 | |
| Sample Variance | 748295.1T | |
| Range | 2.2B | |
| R-Value | (0.77) | |
| Mean Square Error | 330112.9T | |
| R-Squared | 0.59 | |
| Significance | 0.0008 | |
| Slope | (148,620,609) | |
| Total Sum of Squares | 10476131.8T |
Invivyd Market Capitalization History
About Invivyd Financial Statements
Invivyd stakeholders use historical fundamental indicators, such as Invivyd's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Invivyd investors may analyze each financial statement separately, they are all interrelated. For example, changes in Invivyd's assets and liabilities are reflected in the revenues and expenses on Invivyd's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Invivyd. Please read more on our technical analysis and fundamental analysis pages.
Invivyd, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Invivyd, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts. Invivyd operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Invivyd is a strong investment it is important to analyze Invivyd's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Invivyd's future performance. For an informed investment choice regarding Invivyd Stock, refer to the following important reports:Check out the analysis of Invivyd Correlation against competitors. For information on how to trade Invivyd Stock refer to our How to Trade Invivyd Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Invivyd. If investors know Invivyd will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Invivyd listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.95) | Revenue Per Share 0.02 | Return On Assets (0.54) | Return On Equity (0.97) |
The market value of Invivyd is measured differently than its book value, which is the value of Invivyd that is recorded on the company's balance sheet. Investors also form their own opinion of Invivyd's value that differs from its market value or its book value, called intrinsic value, which is Invivyd's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invivyd's market value can be influenced by many factors that don't directly affect Invivyd's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invivyd's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invivyd is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invivyd's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.